Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Shares Outstanding (Weighted Average) (2021 - 2024)

Opus Genetics (IRD) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $178.2 million as the latest value for Q3 2014.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 44.67% to $178.2 million in Q3 2014 year-over-year; TTM through Sep 2014 was $178.2 million, a 44.67% increase, with the full-year FY2013 number at $128.6 million, up 32.44% from a year prior.
  • Shares Outstanding (Weighted Average) was $178.2 million for Q3 2014 at Opus Genetics, roughly flat from $177.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $178.2 million in Q3 2014 to a low of $73.9 million in Q2 2010.
  • A 5-year average of $111.1 million and a median of $95.3 million in 2012 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 0.11% in 2012, then soared 48.67% in 2014.
  • Opus Genetics' Shares Outstanding (Weighted Average) stood at $78.7 million in 2010, then increased by 18.29% to $93.0 million in 2011, then rose by 4.4% to $97.1 million in 2012, then surged by 32.44% to $128.6 million in 2013, then surged by 38.53% to $178.2 million in 2014.
  • Per Business Quant, the three most recent readings for IRD's Shares Outstanding (Weighted Average) are $178.2 million (Q3 2014), $177.7 million (Q2 2014), and $170.1 million (Q1 2014).